Aptevo Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $25.00K.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $86.00K.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $51.00K.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $8.00K.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $623.00K, a 41.59% increase from fiscal 2017.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $440.00K, a 2100.00% increase from fiscal 2016.
- Aptevo Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $20.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-06-30 | $25.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $86.00K 10-Q · filed 2021-08-12 | |
| 2018-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $623.00K 10-K · filed 2020-03-25 |
| 2018-09-30 | $8.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $378.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $186.00K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $440.00K 10-K · filed 2019-03-18 | |
| 2016-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $20.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |